Lisa J. Underland

https://assets.montefioreeinstein.org/profiles/images/Underland_Lisa_DO_2x.jpg

First Name

Lisa

Last Name

Underland

NPI

1598083974

Faculty ID

13753

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

57202

Is Open Scheduling

Off

Molly O. Regelmann

https://assets.montefioreeinstein.org/profiles/images/Regelmann_Molly_MD_2x.jpg

First Name

Molly

Last Name

Regelmann

NPI

1972761237

Faculty ID

15164

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Endocrinology

Elsevier Profile

EMR ID

73286

Biography

<p>Dr. Regelmann is an Assistant Professor of Pediatric Endocrinology and Diabetes at the Children&rsquo;s Hospital at Montefiore. She formerly held the same position at the Icahn School of Medicine at Mount Sinai, where she established herself for clinical excellence, being named a New York Rising Stars Super Doctor and Castle Connolly Top Doctor.</p><p>Dr. Regelmann graduated magna cum laude with high honors in research from Cornell University. She received her medical education at New York University. She completed residency training in general pediatrics and fellowship training in pediatric endocrinology at the Icahn School of Medicine at Mount Sinai.</p>

Is Open Scheduling

On

Katherine M. O'Connor

https://assets.montefioreeinstein.org/profiles/images/OConnor_Katherine_MD_2x.jpg

First Name

Katherine

Last Name

O'Connor

NPI

1194938605

Faculty ID

10973

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>1) Improve the quality of the patient experience at Montefiore, eg. new project to improve comfort during routine phlebotomy at CHAM.</p>

<p>2) Infant and toddler feeding patterns as windows into the origins of pediatric obesity; specifically encouraging breastfeeding and preventing excessive milk consumption.</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Medicine

Research Focus

<span style="background-color:#ffffff;"></span>Research and quality improvement efforts are focused on pain control, topical anesthetic use for venipuncture and improving the patient experience.<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;"></span>

Elsevier Profile

EMR ID

4557

Biography

<p>Katherine O&rsquo;Connor, MD, is an Associate Director in the Division of Hospital Medicine and an Attending Pediatric Hospitalist at Children&rsquo;s Hospital at Montefiore. She is also an Associate Professor of Pediatrics, Albert Einstein College of Medicine. Dr. O&rsquo;Connor joined Montefiore in 2007.</p><p>Dr. O&rsquo;Connor received her Bachelor of Arts in Cognitive Neuroscience in 1999 from Harvard University. In 2003, she received her Medical Doctorate from Columbia University College of Physicians and Surgeons. Dr. O&rsquo;Connor attended Albert Einstein College of Medicine from 2003 to 2007 where she completed an internship and residency in pediatrics.</p><p>Dr. O&rsquo;Connor is an advocate for patient and family comfort. Her research and quality improvement efforts are focused on pain control, topical anesthetic use for venipuncture and improving the patient experience. She is currently working on a study to help educate families about firearm injury prevention in the inpatient setting. Dr. O&rsquo;Connor&rsquo;s work has been published in multiple manuscripts and book chapters. </p><p>Dr. O&rsquo;Connor is board certified by the American Board of Pediatrics and is a member of the American Academy of Pediatrics.</p>

Is Open Scheduling

Off

Marleine F. Ishak

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/5c9fc3e0-35f4-11ed-8123-8ffce84a9f6a.jpg

First Name

Marleine

Last Name

Ishak

NPI

1639321847

Faculty ID

14583

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

73015

Biography

<p>Marleine Ishak, MD, is an attending physician, Respiratory and Sleep Medicine at Children’s Hospital at Montefiore (CHAM) and Assistant Professor, Pediatrics at Montefiore Einstein. Dr Ishak brings unique specialized medical skills, experience and commitment to the care of your child with respiratory disease. She has a particular interest in pediatric asthma and bronchopulmonary dysplasia.</p>

<p>In 2005, Dr. Ishak received her medical degree from the Lebanese University Faculty of Medical Sciences in Beirut, Lebanon. After completing her pediatric residency in 2008 at Saint George Hospital/Balamand in Beirut, she came to the United States and completed her postdoctoral fellowship in pediatric pulmonology at Yale Children’s Hospital in 2011 and her residency in pediatrics at New York-Presbyterian Morgan Stanley Children's Hospital (CHONY) in 2013.</p>

<p>Dr. Ishak’s research focuses on hypoxia. She has shared her work through publication in peer-reviewed journals, book chapters and national presentations.</p>

<p>Dr. Ishak is board certified in both General Pediatrics and Pediatric Pulmonology by the American Board of Pediatrics. She is a member of the American Academy of Pediatrics, American College of Chest Physicians and the American Thoracic Society.</p>

Is Open Scheduling

Off

Daphne T. Hsu

https://assets.montefioreeinstein.org/profiles/images/physphoto/Hsu_Daphne_MD_420x504-1.jpg

First Name

Daphne

Last Name

Hsu

NPI

1689653321

Faculty ID

11172

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Hsu&rsquo;s main research efforts focus on improving outcomes in children and young adults with congenital heart disease and acquired heart diseases of childhood. She has published extensively in the fields of pediatric cardiomyopathy and pediatric heart transplantation. She has conducted outcomes research in drug therapies in the treatmen of pediatric heart failure. She also has a strong interest in the emerging field of adult congenital heart disease. She has served in leadership positions in the American Heart Association, American College of Cardiology, International Society for Heart and Lung Transplantation, American Academy of Pediatrics, American Board of Pediatrics and is a member of the American Pediatric Society.</p>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Hsu is one of the nation's leading experts in children's heart failure and heart transplant. Dr. Hsu brings specialized medical skills, decades of experience-and extraordinary commitment-to the care of children with complex heart disease. She conducts ongoing clinical research and has participated in many US multi-center studies on children's cardiomyopathies, medical and catheter-based therapy for heart disease in children and heart transplant. She is a nationally recongized pediatric cardiologic thought-leader.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

PubMed.gov URL

EMR ID

4960

Biography

<p>Dr. Daphne Hsu, is one of the nation's leading experts in children's heart failure and heart transplant. Dr. Hsu has treated more than 600 children with heart failure and more than 250 children undergoing heart transplant. Past director of Pediatric Heart Failure at New York-Presbyterian Hospital, Dr. Hsu brings unique specialized medical skills, decades of experience-and extraordinary commitment-to the care of your child with complex heart disease.</p><p>When your child is being considered for a heart transplant, Dr. Hsu provides expert evaluation. Before, during and after surgery, she manages the full-spectrum, customized medical therapy-and hands-on specialized care-your child needs for successful heart transplant.</p><p>In addition to managing her busy practice, Dr. Hsu conducts ongoing clinical research and is a nationally recognized pediatric cardiologic thought-leader.</p><p>Since beginning her career in 1987, Dr. Hsu has participated in many important US multi-center studies on children's cardiomyopathies, medical and catheter-based therapy for heart disease in children and heart transplant. Dr. Hsu served on the end-point and steering committee of the only multi-centered, placebo-controlled trial studying the effect of Carvedilol in pediatric heart failure patients.</p><p>Past president and board member of the Pediatric Heart Transplant Study Group, Dr. Hsu also sits on the boards of the Pediatric Cardiomyopathy Registry and the Adult Congenital Heart Disease Committee for the American Heart Association. In addition to authoring dozens of peer-reviewed cardiologic studies (link: p. 41), Dr. Hsu reviews pediatric cardiologic-related grants for the Food and Drug Administration and the National Institutes of Health and is a member of the Sub Board of Pediatric Cardiology of the American Board of Pediatrics.</p><p>Dr. Hsu was drawn to pediatric cardiology early in her career. "I like being able to care for the sickest children," she explains. Children with heart failure "have a terrible disease," says Dr. Hsu. "You have to figure out what it is. You have to treat it quickly. And you have to do it well-and then you can follow them for the rest of their lives." Lasting relationships with her patients-and their families-are for Dr. Hsu among the most rewarding aspects her work. "You can share with the family the joy of this child who is doing so beautifully because you know where they've come from."</p>

Is Open Scheduling

Off

D. Yitzchak Goldstein

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/8c987830-5e93-11ee-94fb-7b66b01a7494.jpg

First Name

D. Yitzchak

Last Name

Goldstein

NPI

1295014991

Faculty ID

15128

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Goldstein completed his medical school training at Einstein and went on to complete his residency and chief residency in anatomic and clinical pathology at Montefiore. With a passion for advanced molecular diagnostics he then went on to complete a molecular genetic pathology fellowship and Mount Sinai hospital.</p>
<p>Dr. Goldstein&rsquo;s interests include several areas of clinical laboratory medicine and laboratory optimization with particular interests in molecular diagnostics and data alanysis. Dr. Goldstein has received accolades for his teaching including the Leo M. Davidoff award for teaching of medical students at Einstein as well as the Montefiore Pathology Department resident teaching award. Dr. Goldstein currently serves as Associate Director of Molecular Infectious Disease Testing and is Co-Director of the Molecular Genetic laboratories at Montefiore.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>Jacob, J., <strong>Goldstein, DY.</strong>, &amp; Gil, M. R. (2019). Molecular Testing in Coagulation. In&nbsp;<em>Transfusion Medicine and Hemostasis</em>&nbsp;(pp. 945-953). Elsevier.</p>
<p>Marks, E., Wang, Y., Shi, Y., Susa, J., Jacobson, M., &amp; <strong>Goldstein, D. Y</strong>. (2018). Specific TCR gene rearrangements in mycosis fungoides: does advanced clinical stage show a preference?.&nbsp;<em>Journal of clinical pathology</em>,&nbsp;<em>71</em>(12), 1072-1077</p>
<p>Patel, S. R., Madan, S., Saeed, O., <strong>Goldstein, D.Y.</strong>, Shin, J. J., Nucci, C., ... &amp; Vukelic, S. (2018). Cardiac transplantation from non-viremic hepatitis C donors.&nbsp;<em>The Journal of Heart and Lung Transplantation</em>,&nbsp;<em>37</em>(10), 1254-1260.</p>
<p>Kim, T., Khader, S. N., &amp; <strong>Goldstein, D. Y.</strong> (2018). Educational Case: Cervical Neoplasia: HPV and Its Link to Cancer.&nbsp;<em>Academic Pathology</em>,&nbsp;<em>5</em>, 2374289518770651.</p>
<p>Castellucci, E., He, T., <strong>Goldstein, D. Y.</strong>, Halmos, B., &amp; Chuy, J. (2017). DNA polymerase ɛ deficiency leading to an ultramutator phenotype: a novel clinically relevant entity.&nbsp;<em>The oncologist</em>,&nbsp;<em>22</em>(5), 497-502.</p>
<p><strong>Goldstein, D. Y.,</strong> &amp; Prystowsky, M. (2017). Educational Case: Autosomal Recessive Inheritance: Cystic Fibrosis.&nbsp;<em>Academic pathology</em>,&nbsp;<em>4</em>, 2374289517691769.</p>

EMR ID

54210

Is Open Scheduling

Off

Pe'er Dar

https://assets.montefioreeinstein.org/profiles/images/physphoto/Peer_Dar_MD_420x504.jpg

First Name

Pe'er

Last Name

Dar

NPI

1801976386

Faculty ID

10177

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr Dar is the director of the division of fetal medicine at Montefiore Medical Center.&nbsp;He&nbsp;was trained in obstetrics and&nbsp;gynecology and&nbsp;high risk pregnancy in Israel and&nbsp;completed&nbsp;further training in obstetrics and gynecology and clinical genetics in the USA. In addition, Dr Dar&nbsp;completed training in fetal surgery in Europe.</p>
<p>Dr Dar is specialized in:</p>
<p>1.&nbsp;Prenatal diagnosis: Prenetal&nbsp;screening including First trimester screening for Down syndrome; Detailed fetal anatomy scans in early and&nbsp;late second trimester (including early transvaginal scans); Fetal echocardiography;&nbsp;Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies.</p>
<p>2. In Utero procedures and surgery: Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome,&nbsp;EXIT procedures, Selective fetal reductions, fetal blood transfusions,&nbsp;in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts;&nbsp;</p>

Areas of Expertise

Expert Summary

<p>Dr. Dar was trained in obstetrics and gynecology and high risk pregnancy in Israel and completed further training in obstetrics and gynecology and clinical genetics in the U.S. In addition, Dr. Dar completed training in fetal surgery in Europe. Dr. Dar specializes in prenatal screening, including first trimester screening for Down syndrome; Detailed fetal anatomy scans in early and late second trimester (including early transvaginal scans); Fetal echocardiography; Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies. He also performs in utero procedures and surgery, which includes Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome, EXIT procedures, Selective fetal reductions, fetal blood transfusions, in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts.</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

<table><tbody><tr><td><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal diagnosis by ultrasound of placental and fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal genetic diagnosis of fetal disorders</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of pregnancies complicated by all fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of complicated twin and other multiple pregnancies </span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal therapy</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal surgery including fetsocopic surgery for TTTS </span> </td></tr></tbody></table>

Research Focus

<p style="line-height:150%;">Fetal medicine and surgery</p><p style="line-height:150%;">Non-invasive prenatal screening (cell free DNA)</p><p style="line-height:150%;">Scar pregnancies and placenta accreta spectrum (PAS)</p><p style="line-height:150%;">Ultrasound in obstetrics and gynecology</p>

Elsevier Profile

Selected Publications

<p style="text-align: left; padding-left: 30px;">1. Mazor M, <strong>Zitzer P</strong>, Chaim W, Maymon E, Kuperman O<em>. C-reactive protein as a marker of infection in women with preterm delivery.</em> Harefuah.[Hebrew] 1993:1;124(3); 132-137.</p>
<p style="text-align: left; padding-left: 30px;">2. Maymon R, <strong>Zitzer P</strong>, Manor Y, Bukovsky I, Moroz C<em>. Placental isoferitin patterns&nbsp; during normal first trimester and tubal gestations</em>. Hum Reprod. 1995:10(9); 2445-2447.</p>
<p style="text-align: left; padding-left: 30px;">3. Langer R, Pansky M,<strong> Zitzer P</strong>, Bukovsky I, Golan A<em>. National Urogynecologic Survey</em>. Isr J Obstet Gynecol. 1996 :7;145-149.</p>
<p style="text-align: left; padding-left: 30px;">4. <strong>Zitzer P</strong>, Panski M, Maymon R, Langer R, Bukovski I, Golan A. <em>Pelvic splenosis as a cause of low abdominal pain- Laparoscopic management</em>. Human Reprod. 1998 :13(6);101-103.</p>
<p style="text-align: left; padding-left: 30px;">5. Arieli S, <strong>Zitzer P</strong>, Bukovsky I, Maymon R<em>. Metabolic alkalosis at term pregnancy causing fetal deterioration and distress. </em>Isr J Obstet Gynecol 1999: 10; 61-63</p>
<p style="text-align: left; padding-left: 30px;">6. <strong>Dar P</strong>, Weiner I, Sofrin O, Sachs GS, Bukovsky I, Arieli S. <em>Clinical and sonographic fetal weight estimations in active labor with ruptured membranes</em>. J Reprod Med. 2000:45(5); 390-394.</p>
<p style="text-align: left; padding-left: 30px;">7. &nbsp;<strong>Dar P,</strong> Gross SJ. <em>Craniofacial and neck anomalies</em>. Clin Perinatol 2000;27(4);813-837</p>
<p style="text-align: left; padding-left: 30px;">8. <strong>Dar P</strong>, Gross SJ. <em>Macrosomia-a genetic perspective</em>. Clin Obstet Gynecol. 2000:43(2); 298-308.</p>
<p style="text-align: left; padding-left: 30px;">9. <strong>Dar P</strong>, Sachs GS, Strassburger D, Bukovsky I, Arieli S. <em>Ovarian function before and after salpingectomy in artificial reproductive technology patients</em>. Hum Reprod. 2000:15(1);142-144</p>
<p style="text-align: left; padding-left: 30px;">10. <strong>Dar P,</strong> Sachs SG, Carter SM, Ferreira JC, Nitowsky HM, Gross SJ. <em>Prenatal diagnosis of Bardet-Biedl syndrome by targeted second trimester sonography. </em>Ultrasound Obstet Gynecol 2001 Apr;17(4):354-6</p>
<p style="text-align: left; padding-left: 30px;">11. Sherer DM, <strong>Dar P</strong>. <em>Prenatal ultrasonographic diagnosis of congenital umbilical hernia and associated patent omphalomesenteric duct</em>. Gynecol Obstet Invest. 2001:51(1); 66-68</p>
<p style="text-align: left; padding-left: 30px;">12<em>.</em><strong> Dar P</strong>, Strassburger D, Shaish A, Levkovitz H, Halperin R, Harats R<em>.</em><em> Reduced reproduction with increased abortion rate in transgenic mice that overexpress 15-Lipoxygenase.</em>Gynecol Obstet Invest. 2001;52(1):18-21.</p>
<p style="text-align: left; padding-left: 30px;">13. <strong>Dar P</strong>, Javed AA, Ben-Yishay M, Ferreira JC, Paterson AD, Gross SJ, Chitayat D, Morrow BE, Nitowsky HM. <em>Potential Mapping of Corneal Dermoids to Xq24-qter</em>. J Med Genetics. 2001;38(10):719-23</p>
<p style="text-align: left; padding-left: 30px;">14. Halperin R, Zehavi S, <strong>Dar P</strong>, Habler L, Hadas E, Bukovsky I, Schneider D<em>. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas</em>. Eur J Gynaecol Oncol. 2001;22(4):292-6.</p>
<p style="text-align: left; padding-left: 30px;">15. Gross SJ, Ferreira JC, Morrow BE, <strong>Dar P,</strong> Funke B, Khabele D, Merkatz I. Gene expression profile of trisomy-21 placentas &ndash; a potential approach for designing non-invasive techniques of prenatal diagnosis. Am J Obstet Gynecol. 2002. 187(2):457-62</p>
<p style="text-align: left; padding-left: 30px;">16. Vaknin Z, Halperin R, Schneider D, Teitler J, <strong>Dar P</strong>, Herman A, Herman A, Berkovitch M. <em>Hyperemesis gravidarum and nonspecific abnormal EEG findings: a preliminary </em>report. J Reprod Med. 2006 ;51(8):623-7.</p>
<p style="text-align: left; padding-left: 30px;">17. Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. <em>Comparison of Serum Markers in First-Trimester Down Syndrome Screening.</em> Obstet Gynecol. 2006 ;108(5):1192-1199.</p>
<p style="text-align: left; padding-left: 30px;">18. Dugoff L, Cuckle HS, Hobbins JC,&nbsp; Malone FD, Belfort MA, Nyberg DA,&nbsp; Comstock CH,&nbsp; Saade GR, Eddelman KA, <strong>Dar P,</strong>&nbsp; Craigo AD,&nbsp; Timor Tritsch IE, Carr SR, Wolfe HM, D&rsquo;alton ME ^&nbsp;for the FASTER Trial Research Consortium. <em>Prediction of patient-specific risk for fetal loss using maternal characteristics and first and second trimester maternal serum Down syndrome markers.</em>&nbsp; Am J Obstet Gynecol. 2008 Sep;199(3):290.e1-6.</p>
<p style="text-align: left; padding-left: 30px;">19. <strong>Dar P,</strong> Karmin I, Einstein MH. <em>Arteriovenous Malformations of the Uterus: Long-Term Follow-Up.</em> Gynecol Obstet Invest. 2008 11;66(3):157-161</p>
<p style="text-align: left; padding-left: 30px;">20. Rotenberg, O., Shahabi, S., Dar, P. <em>Testosterone secreting mature ovarian teratoma causing virilization in an adolescent - Sonographic and color Doppler characteristics.</em> J Ultrasound Med. 2009 ;28(1):85-8</p>
<p style="text-align: left; padding-left: 30px;">21. D&rsquo;Alton ME, Cleary-Goldman J,&nbsp; Lambert-Messerlian G, Ball RH,&nbsp; Nyberg DA,&nbsp; Comstock CH,&nbsp; Bukowski R, Berkowitz RL,&nbsp; <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes K,&nbsp; Canick JA, Malone FD. <em>Maintaining quality assurance for nuchal translucency sonography: Lessons from the FASTER trial</em>.&nbsp; Ultrasound Obstet Gynecol. 2009 27;33(2):142-146</p>
<p style="text-align: left; padding-left: 30px;">22. Gebb J, <strong>Dar P</strong>. <em>Should the First Trimester Aneuploidy Screen be Maternal Age Adjusted? Screening by Absolute Risk vs. Risk Adjusted to Maternal Age.</em> Prenatal Diagnosis. 2009; 29 (3) 245-247</p>
<p style="text-align: left; padding-left: 30px;">23. Terry S., Banks E., Harris K., Duvivier R., <strong>Dar P</strong>. <em>Comparison of 3-dimensional to 2-dimensional Saline Infusion Sonohysterograms for the Evaluation of Intrauterine Abnormalities.</em> J Clinic Ultrasound. 2009 ;37(5):258-62.</p>
<p style="text-align: left; padding-left: 30px;">24. <strong>Dar P</strong>, Rosenthal J,Factor S, DubiossoR, Murthy AS <em>First trimester diagnosis of fetal epignathus with two and three-dimensional ultrasonography</em><strong>. </strong>J Ultrasound Med. 2009 Dec;28(12):1743-6</p>
<p style="text-align: left; padding-left: 30px;">25.&nbsp; Ram K, Goffman D, Ilagan J, <strong>Dar P</strong>. <em>First trimester diagnosis of familial split-hand split-foot malformation (SHFM)</em>. J Ultrasound Med. 2009 ;28(10):1397-400.</p>
<p style="text-align: left; padding-left: 30px;">26. <strong>Dar P</strong>, Gebb J, Reimers L, Bernstein PB, Chazotte C, Merkatz IR. <em>First trimester 3-dimensional power Doppler of the utero-placental circulation space: A potential screening method for preeclampsia. </em>AJOG. 2010 ;203(3):238.e1-7.</p>
<p style="text-align: left; padding-left: 30px;">27. <strong>Dar P</strong>, Gebb J. <em>Reply: First-trimester 3-dimensional power Doppler for the screening of preeclampsia: the analysis of a greater proportion of the uteroplacental unit might improve the accuracy of the method </em>.AJOG. 2011 Feb;204(2):e5-6.</p>
<p style="text-align: left; padding-left: 30px;">28. Gebb J, Demasio K, <strong>Dar P</strong>. <em>Prenatal sonographic diagnosis of a familial Saethre-Chotzen Syndrome. </em>J Ultrasound Med. 2011;30(3):420-2</p>
<p style="text-align: left; padding-left: 30px;">29. Gebb J, <strong>Dar P</strong>. <em>Color Doppler ultrasound of spiral artery blood flow in the prediction of preeclampsia and intrauterine growth restriction</em>. Best Prac Res Clin Obstet Gynecol. 2011. In press</p>

EMR ID

4197

Biography

<p>Pe&rsquo;er Dar, MD, is Director of Fetal Medicine and OBGYN Ultrasound at Montefiore and Professor of Obstetrics and Gynecology and Women&rsquo;s Health at our Albert Einstein College of Medicine. Dr. Dar&rsquo;s clinical focus is on the care of women who carry babies with disorders and medical conditions that may affect their lives and he leads the Fetal Medicine and Surgery Team at Montefiore. He particularly specializes in diagnosis and management of medical and structural abnormalities in the fetus and in complicated twin and triplet pregnancies. His expertise include performing detailed ultrasound examination of the fetus including fetal echocardiography (scanning of the fetal heart) and fetal neurosonography (scanning of the fetal brain) as well as performing in-utero fetal surgeries such as fetoscopic laser surgery for monochorionic twins with twin to twin transfusion syndrome, in-utero blood transfusion for fetuses with anemia and in-utero drainage and shunt procedures. Dr. Dar is also experienced in performing amniocentesis, chorionic villous sampling (CVS) and multifetal selective reduction for multiple pregnancies.&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Dr. Dar completed his Doctor of Medicine from Tel-Aviv University in Tel-Aviv, Israel in 1986. He started his postgraduate education at Assaf Harofe Medical Center, Tel-Aviv University, with a residency in obstetrics and gynecology and a specialty in high-risk pregnancies from 1992 through 1998. He then came to Montefiore-Einstein, completing a two-year fellowship in medical and reproductive genetics. After spending two years as an attending-specialist in the field of prenatal diagnosis he completed in 2005 three-year residency in obstetrics and gynecology at Montefiore-Einstein. In 2007, he completed additional training in fetal surgery in world-known fetal surgery centers in France and Belgium. &nbsp;</p><p>Dr. Dar is very active in research and he is currently the principal investigator in many studies including international multicenter studies. His research focus is in fetal medicine and surgery, non-invasive prenatal screening and placenta accreta spectrum. He has shared his work in many peer-reviewed journals, textbook chapters, abstracts and invited presentations. He is also a reviewer for national and international journals including the <em>American Journal of Obstetrics and Gynecology, Plos one and Prenatal Diagnosis. </em></p><p>Dr. Dar is board certified in both Obstetrics and Gynecology and Clinical Genetics and is a member of several professional societies including the Society of Maternal and Fetal Medicine, International Fetal Medicine and Surgery Society and the International Society of Ultrasound in Obstetrics and Gynecology. He has been regularly listed among Castle Connolly Top Doctors for obstetrics and gynecology in the New York Metro area.</p>

Is Open Scheduling

Off

Tamar Baer

https://assets.montefioreeinstein.org/profiles/images/physphoto/Baer_Tamar_MD_420x504.jpg

First Name

Tamar

Last Name

Baer

NPI

1497022503

Faculty ID

15950

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

53480

Biography

<p>Tamar G. Baer, MD, is Associate Fellowship Program Director, Pediatric Endocrinology & Diabetes at Children&rsquo;s Hospital at Montefiore, and Assistant Professor, Pediatrics at Montefiore Einstein. Her clinical focus is in pediatric endocrinology, differences in sexual development, and diabetes.</p><p>After completing her Bachelor of Arts in psychology in 2007 at Barnard College, Columbia University, Dr. Baer pursued her medical education at Einstein, earning her Doctor of Medicine in 2011. She continued at Einstein for her internship and residency in pediatrics, completing her chief residency in 2015. She continued her postdoctoral training at Columbia University Medical Center, completing a three-year fellowship in pediatric endocrinology, diabetes and metabolism in 2018.</p><p>Dr. Baer&rsquo;s research follows her clinical interest in medical education, wellbeing in medical training, pediatric endocrinology and diabetes. She has shared her research through peer-reviewed journals and poster presentations.</p><p>Dr. Baer is board certified in Pediatrics and Pediatric Endocrinology by the American Board of Pediatrics.</p>

Is Open Scheduling

Off

Gabriella C. Azzarone

https://assets.montefioreeinstein.org/profiles/images/Azzarone_Gabriella_MD_2x.jpg

First Name

Gabriella

Last Name

Azzarone

NPI

1780895045

Faculty ID

10971

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Pediatric Hospital Medicine</p>

<p>Medical Student &#38;&#160;Resident Education</p>

<p>In-Patient Asthma Management</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

4549

Biography

<p>Gabriella C. Azzarone, MD, FAAP, is an attending physician at the Children&rsquo;s Hospital at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. She is also Co-Director, Pediatrics Clerkship and Course Director, Pediatrics Acting Internship at Einstein. Dr. Azzarone&rsquo;s clinical focus is in pediatric care, ensuring safe and quality care for hospitalized children.</p><p>In 1996, Dr. Azzarone received her Bachelor of Arts from Barnard College, Columbia University, then completed her postbaccalaureate premedical studies at the same institution in 1998. In 2003, she earned her Doctor of Medicine from New York University School of Medicine. For her postgraduate training, Dr. Azzarone came to Einstein, completing her internship and residency in pediatrics in 2007, taking on the role of Chief Resident in her final year. In 2015, Dr. Azzarone completed a clinical quality fellowship program with the Greater New York Hospital Association and United Hospital Fund.</p><p>Dr. Azzarone&rsquo;s research focus is on the inpatient management of pediatric respiratory illnesses and firearm-related violence prevention through education, advocacy, research and clinical care. She has shared her work through peer-reviewed journals, book chapters, review articles, abstracts, workshops and invited presentations. She is also an ad hoc reviewer for <em>Pediatrics</em> and <em>Hospital Pediatrics</em>.</p><p>Dr. Azzarone is a Diplomate of the American Board of Pediatrics. She is a Fellow of the American Academy of Pediatrics and a member of the American Medical Association. In 2017, Dr. Azzarone was inducted into the Leo M. Davidoff Society.</p>

Is Open Scheduling

Off

Sandra Aleksic

https://assets.montefioreeinstein.org/profiles/images/physphoto/Aleksic_Sandra_MD_420x504.jpg

First Name

Sandra

Last Name

Aleksic

NPI

1265864409

Faculty ID

16275

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; text-align: justify;"><span style="font-family: Calibri, sans-serif;">Dr. Sandra Aleksic is an Assistant Professor in Department of Medicine, Division of Endocrinology and Geriatrics. She earned her medical degree from the University of Belgrade Faculty of Medicine in Serbia. She completed residency in internal medicine at Rutgers New Jersey Medical School and fellowship in endocrinology, diabetes and metabolism at Montefiore Medical Center/Albert Einstein College of Medicine. She earned a Master of Science in Clinical Research Methods through Einstein&rsquo;s Clinical Research Training Program. She is the recipient of a Career Development Award from the Einstein/Montefiore Institute for Clinical and Translational Research, Resnick Emerging Scholar in Aging Research Award and Paul B. Beeson Emerging Leaders Career Development Award in Aging.&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; text-align: justify;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; text-align: justify;">Dr. Aleksic&rsquo;s research aims to uncover metabolic and endocrine mechanisms underlying healthy aging and longevity. Specifically, her translational research is focused on neuroendocrine regulation of aging and the role of the hypothalamus in human aging. Her team utilizes novel MRI-based methods to assess hypothalamic microstructure in order to elucidate its role in neuroendocrine and metabolic disturbances that underlie unhealthy aging and development of age-related disease.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><strong><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">Selected Publications:</span></span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull;&nbsp;</span></span><span style="color: #212121; font-family: 'system-ui', -apple-system, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Fira Sans', 'Droid Sans', 'Helvetica Neue', sans-serif; font-size: 16px;"><strong>Aleksic S,</strong> Desai D, Ye K, Duran S, Gao T, Crandall J, Atzmon G, Barzilai N, Milman S. Integrity of hypothalamic-pituitary-testicular axis in exceptional longevity. Aging Cell. 2022 Jun 29:e13656. doi: 10.1111/acel.13656. Epub ahead of print. PMID: 35770332.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull; </span></span><span style="font-size: 11.0pt; font-family: 'Arial',sans-serif;">Kulkarni AS*, <strong>Aleksic S</strong>*, Berger DM, Sierra F, Kuchel GA, Barzilai N. Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization. Aging Cell. 2022 Apr;21(4):e13596. doi: 10.1111/acel.13596. Epub 2022 Mar 27. PMID: 35343051; PMCID: PMC9009114 <strong><span style="color: #212121; background: white;">(*equally contributed)</span></strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull;&nbsp;</span></span><span style="font-family: Calibri, sans-serif; font-size: 16px;">Lontchi-Yimagou E*, </span><strong style="font-family: Calibri, sans-serif; font-size: 16px;">Aleksic S*,</strong><span style="font-family: Calibri, sans-serif; font-size: 16px;">&nbsp;Hulkower R, et al. Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure.&nbsp;</span><em style="font-family: Calibri, sans-serif; font-size: 16px;">J Clin Endocrinol Metab</em><span style="font-family: Calibri, sans-serif; font-size: 16px;">. 2020;105(11):dgaa539. PMID: 32915987. </span><span style="font-size: 11.0pt; font-family: 'Arial',sans-serif;"><strong><span style="color: #212121; background: white;">(*equally contributed)</span></strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull; <strong>Aleksic S</strong>, Eisenberg R, Tsomos E, et al. Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and</span></span> posttransplantation<span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"> diabetes: A single-center retrospective study. Diabetes Res Clin Pract. 2020 Jul;165:108221. PMCID: PMC7415727.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&nbsp;</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull; Carey M, Lontchi-Yimagou E, Mitchell W, Reda S, Zhang K, Kehlenbrink S, Koppaka S, Maginley SR, <strong>Aleksic S</strong>, Bhansali S, Huffman DM, Hawkins M. Central KATP Channels Modulate Glucose Effectiveness in Humans and Rodents. Diabetes. 2020 Jun;69(6):1140-1148. PMCID: PMC7243288.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&nbsp;</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull; Zhang WB*, <strong>Aleksic S*</strong>, Gao T, et al. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults. Cells. 2020 Jun 1;9(6). PMCID: PMC7349399. </span></span><span style="font-size: 11.0pt; font-family: 'Arial',sans-serif;"><strong><span style="color: #212121; background: white;">(*equally contributed)</span></strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&nbsp;</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull; Jotic A, Milicic T, Covickovic Sternic N, Kostic VS, Lalic K, Jeremic V, Mijailovic M, Lukic L, Rajkovic N, Civcic M, Macesic M, Seferovic JP, Stanarcic J, <strong>Aleksic S</strong>, Lalic NM. Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke. Int J Endocrinol. 2015;2015:934791. PMCID: PMC4452095.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull; Milicic T, Jotic A, Markovic I, Lalic K, Jeremic V, Lukic L, Rajkovic N, Popadic D, Macesic M, Seferovic JP, <strong>Aleksic S</strong>, Stanarcic J, Civcic M, Lalic NM. High Risk First Degree Relatives of Type 1 Diabetics: An Association with Increases in CXCR3(+) T Memory Cells Reflecting an Enhanced Activity of Th1 Autoimmune Response. Int J Endocrinol. 2014;2014:589360. PMCID: PMC3979071.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&nbsp;</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&bull; Jotic A, Covickovic Sternic N, Kostic VS, Lalic K, Milicic T, Mijailovic M, Lukic Lj, Civcic M, Colak E, Macesic M, Seferovic JP, <strong>Aleksic S</strong>, Lalic N. Type 2 Diabetic Patients with Ischemic Stroke: Decreased Insulin Sensitivity and Decreases in Antioxidant Enzyme Activity Are Related to Different Stroke Subtypes. Int J Endocrinol. 2013;2013:401609. PMCID: PMC3697295.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">&nbsp;</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; text-align: justify;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; text-align: justify;"><span style="font-size: 12pt;">&nbsp;</span></p>

EMR ID

88114

Visit Type ID

2499

Is Open Scheduling

On

Zocdoc Link